CLINICAL_TRIALS
trial_result
· 2025-08-08
Clinical Trial Update: Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA). [Phase 2]
Summary
Phase 2 trial evaluating aflibercept for inflammatory choroidal neovascularization in young patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hospices Civils de Lyon | Conditions: Inflammatory Choroidal Neovascularization | Phase 2 | Status: COMPLETED